SUD Diagnostic Panel for Urine Sample Integrity Validation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug use screening methods are ineffective due to the widespread use of subversion techniques, which compromise the accuracy of urine sample testing, leading to flawed data and inadequate treatment for substance use disorders, particularly in teenagers, as they can only detect a limited number of subversion methods and fail to validate sample integrity.
Innovation Solution
A comprehensive SUD Diagnostic Panel comprising six assays that detect all twelve recognized classes of subversion techniques, including pH, creatinine, Specific Gravity Index, and bio-marker assays, to validate sample integrity before proceeding with further testing, ensuring accurate drug use detection and diagnosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current automated drug screening methods are used, then testing efficiency is maintained, but detection accuracy deteriorates due to inability to detect most subversion techniques
Solution Approach 1:
The screening process is divided into two distinct segments: (1) a validity assessment step that evaluates sample integrity using multiple parameters (pH, creatinine, specific gravity, oxidant levels), and (2) a drug detection step that occurs only if validity is confirmed. This segmentation allows the system to maintain simplicity while improving accuracy by filtering out adulterated samples before drug screening.
Solution Approach 2:
The patent implements preliminary validation testing before the main drug screening process. By assessing sample validity first (checking for subversion agents, proper composition, and integrity), the system prevents false results from contaminated or adulterated samples from reaching the drug detection phase, thereby improving overall detection accuracy without significantly increasing complexity.
2Reliability
If comprehensive validation of all twelve subversion classes is implemented, then sample validity is improved, but testing time increases
Solution Approach 1:
Multiple validation parameters (pH measurement, creatinine detection, specific gravity assessment, and oxidant level testing) are merged into a single integrated validity assessment workflow. This combined approach evaluates all aspects of sample integrity simultaneously rather than sequentially, improving reliability while minimizing the time added to the testing process.
Solution Approach 2:
The patent employs disposable test strips or reagent cartridges that perform multiple validation functions in a single use. These pre-packaged validation kits contain all necessary reagents for assessing pH, creatinine, specific gravity, and oxidant levels, eliminating the need for complex reusable equipment and reducing both validation time and equipment complexity.
3Measurement precision
If current screening methods are used, then false negatives occur due to subversion masking, but increasing detection capability reduces treatment access
Solution Approach 1:
The system implements a feedback mechanism where validity assessment results directly influence the progression to drug screening. Samples that fail validity checks (indicating potential subversion) are flagged and excluded from drug testing, preventing false negatives. This feedback loop ensures that only valid samples proceed, maintaining high detection accuracy while avoiding unnecessary treatment referrals for adulterated samples.
Solution Approach 2:
By performing preliminary validity assessment before drug screening, the system prevents false negatives caused by subverted samples from triggering unnecessary treatment protocols. This preliminary filter ensures that treatment access is maintained for genuine cases while blocking false positives from adulterated samples, thereby improving both detection accuracy and treatment efficiency.
Data Source
AI summary
Assays and methods for verifying the validity of a urine sample submitted for Drugs of Abuse (DOA) testing. Embodiments include a SUD Diagnostic Panel that includes six assays: specific gravity index assay, long-duration counterfeit urine assay, short-duration counterfeit urine assay, oxidant history assay, pH assay, and creatinine assay. The SUD Diagnostic Panel detects twelve principle classes of adulteration. Detection of adulteration of one or more urine samples from a patient indicates an attempt to subvert test results and provides an objective indication in one instance and an object diagnosis in another instance of SUD.